{"text": ["Lilly", ":", "Phase", "3", "Soft", "Tissue", "Sarcoma", "Study", "Fails", "To", "Meet", "Primary", "Endpoints"], "created_at": "2019-01-19 19:38:00"}
{"text": ["Lilly", ":", "Phase", "3", "Soft", "Tissue", "Sarcoma", "Study", "Fails", "To", "Meet", "Primary", "Endpoints"], "created_at": "2019-01-19 19:38:00"}
{"text": ["[$$]", "Eli", "Lilly\u2019s", "Sarcoma", "Drug", "Combo", "Proves", "Ineffective", "in", "Trials"], "created_at": "2019-01-19 00:42:12"}
{"text": ["Eli", "Lilly", "News:", "LLY", "Stock", "Falls", "on", "Sarcoma", "Study", "Failure"], "created_at": "2019-01-19 00:38:56"}
{"text": ["Eli", "Lilly", "News:", "LLY", "Stock", "Falls", "on", "Sarcoma", "Study", "Failure"], "created_at": "2019-01-19 00:38:56"}
{"text": ["Lilly", "Phase", "3", "REACH-2", "Trial", "Data", "Published", "in", "The", "Lancet", "Oncology", "Shows", "Improvement", "in", "Overall", "Survival", "with", "CYRAMZA\u00ae", "(ramucirumab)", "in", "Second-Line", "AFP-High", "Hepatocellular", "Carcinoma", "Patients"], "created_at": "2019-01-19 00:02:00"}
